NCT05836584 2026-04-21
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
Hospital Universitari de Bellvitge
Sichuan University
Eastern Cooperative Oncology Group
University of Washington
University of Kentucky
Martini-Klinik am UKE GmbH
Mayo Clinic
University of Washington
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Chongqing University Cancer Hospital